191 related articles for article (PubMed ID: 32068452)
21. Novel targeted strategies to overcome resistance in small-cell lung cancer: focus on PARP inhibitors and rovalpituzumab tesirine.
Van Den Borg R; Leonetti A; Tiseo M; Giovannetti E; Peters GJ
Expert Rev Anticancer Ther; 2019 Jun; 19(6):461-471. PubMed ID: 31148500
[No Abstract] [Full Text] [Related]
22. Advances in the treatment of small-cell lung cancer.
Kalemkerian GP
Semin Respir Crit Care Med; 2011 Feb; 32(1):94-101. PubMed ID: 21500128
[TBL] [Abstract][Full Text] [Related]
23. Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer.
Chu X; Li S; Xia B; Chu L; Yang X; Ni J; Zou L; Li Y; Xie C; Lin J; Zhu Z
Radiat Oncol; 2019 Sep; 14(1):171. PubMed ID: 31533763
[TBL] [Abstract][Full Text] [Related]
24. Targeted therapies for small cell lung cancer: Where do we stand?
Arcaro A
Crit Rev Oncol Hematol; 2015 Aug; 95(2):154-64. PubMed ID: 25800975
[TBL] [Abstract][Full Text] [Related]
25. Accurate treatment of small cell lung cancer: Current progress, new challenges and expectations.
Zhang C; Wang H
Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188798. PubMed ID: 36096336
[TBL] [Abstract][Full Text] [Related]
26. Applied models and molecular characteristics of small cell lung cancer.
Fűr GM; Nemes K; Magó É; Benő AÁ; Topolcsányi P; Moldvay J; Pongor LS
Pathol Oncol Res; 2024; 30():1611743. PubMed ID: 38711976
[TBL] [Abstract][Full Text] [Related]
27. Analysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702).
Furuta M; Sakakibara-Konishi J; Kikuchi H; Yokouchi H; Nishihara H; Minemura H; Harada M; Yamazaki S; Akie K; Fujita Y; Takamura K; Kojima T; Harada T; Minami Y; Watanabe N; Oizumi S; Suzuki H; Nishimura M; Dosaka-Akita H; Isobe H;
Oncologist; 2019 Nov; 24(11):e1172-e1179. PubMed ID: 31068386
[TBL] [Abstract][Full Text] [Related]
28. Molecular subtyping of small cell lung cancer.
Liang J; Guan X; Bao G; Yao Y; Zhong X
Semin Cancer Biol; 2022 Nov; 86(Pt 2):450-462. PubMed ID: 35609720
[TBL] [Abstract][Full Text] [Related]
29. Personalized Therapy of Small Cell Lung Cancer.
Schneider BJ; Kalemkerian GP
Adv Exp Med Biol; 2016; 890():149-74. PubMed ID: 26703804
[TBL] [Abstract][Full Text] [Related]
30. New Approaches to SCLC Therapy: From the Laboratory to the Clinic.
Poirier JT; George J; Owonikoko TK; Berns A; Brambilla E; Byers LA; Carbone D; Chen HJ; Christensen CL; Dive C; Farago AF; Govindan R; Hann C; Hellmann MD; Horn L; Johnson JE; Ju YS; Kang S; Krasnow M; Lee J; Lee SH; Lehman J; Lok B; Lovly C; MacPherson D; McFadden D; Minna J; Oser M; Park K; Park KS; Pommier Y; Quaranta V; Ready N; Sage J; Scagliotti G; Sos ML; Sutherland KD; Travis WD; Vakoc CR; Wait SJ; Wistuba I; Wong KK; Zhang H; Daigneault J; Wiens J; Rudin CM; Oliver TG
J Thorac Oncol; 2020 Apr; 15(4):520-540. PubMed ID: 32018053
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM
Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754
[TBL] [Abstract][Full Text] [Related]
32. Management of Small Cell Lung Cancer: Progress and Updates.
Altan M; Chiang AC
Cancer J; 2015; 21(5):425-33. PubMed ID: 26389768
[TBL] [Abstract][Full Text] [Related]
33. [Advances in Molecular Subtyping, Characteristics and Therapeutic Strategies of
Small Cell Lung Cancer].
Wu Y; Zhao J; Wang M
Zhongguo Fei Ai Za Zhi; 2023 Apr; 26(4):303-309. PubMed ID: 37183645
[TBL] [Abstract][Full Text] [Related]
34. Notch pathway in small-cell lung cancer: from preclinical evidence to therapeutic challenges.
Leonetti A; Facchinetti F; Minari R; Cortellini A; Rolfo CD; Giovannetti E; Tiseo M
Cell Oncol (Dordr); 2019 Jun; 42(3):261-273. PubMed ID: 30968324
[TBL] [Abstract][Full Text] [Related]
35. Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance.
Jin Y; Chen Y; Qin Z; Hu L; Guo C; Ji H
Acta Biochim Biophys Sin (Shanghai); 2023 May; 55(6):948-955. PubMed ID: 37249335
[TBL] [Abstract][Full Text] [Related]
36. Second-line treatments of small-cell lung cancers.
Baize N; Monnet I; Greillier L; Quere G; Kerjouan M; Janicot H; Vergnenegre A; Auliac JB; Chouaid C
Expert Rev Anticancer Ther; 2017 Nov; 17(11):1033-1043. PubMed ID: 28849951
[TBL] [Abstract][Full Text] [Related]
37. Recent developments in the treatment of small cell lung cancer.
Hiddinga BI; Raskin J; Janssens A; Pauwels P; Van Meerbeeck JP
Eur Respir Rev; 2021 Sep; 30(161):. PubMed ID: 34261744
[TBL] [Abstract][Full Text] [Related]
38. Development of antibody therapeutics for small cell lung cancer.
Zhan J; Han Q; Wang K
Expert Opin Investig Drugs; 2013 Feb; 22(2):235-44. PubMed ID: 23176362
[TBL] [Abstract][Full Text] [Related]
39. Big Decisions on Small Cell Lung Cancer: A Focus on Clinical Care Updates and Patient Perspectives.
Wang X; Chiang AC
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432520. PubMed ID: 38830134
[TBL] [Abstract][Full Text] [Related]
40. Potential subtype-specific therapeutic approaches in small cell lung cancer.
Horvath L; Lang C; Boettiger K; Aigner C; Dome B; Megyesfalvi Z
Curr Opin Oncol; 2024 Jan; 36(1):51-56. PubMed ID: 37865844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
